Recruiting NA Chronic Obstructive Pulmonary Disease

New treatment option for Chronic Obstructive Pulmonary Disease

Official title Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

ClinicalTrials.gov ID: NCT06390345

What this study is testing

What it's testing
The investigators will conduct a Type I hybrid effectiveness-implementation study to test an integrated telehealth intervention among 400 overweight and obese patients with Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA). The investigators will include eligible participants receiving primary care at one of five Department of Veterans Affairs (VA) medical centers and their community-based outpatient clinics.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • COPD: Defined by presence of airflow obstruction (FEV1/FVC \< 0.70) on post-bronchodilator spirometry
  • ≥10 pack year history of tobacco use
  • Self-reported clinician diagnosis of OSA (or presence of OSA on research HSAT)
  • BMI ≥ 25 kg/m2
  • Symptoms of dyspnea defined by MMRC score of ≥1

You likely can't join if

  • Self-report of weight change \>15 lbs. during prior 3 months
  • Current active weight loss treatment, including: 1) research-based commercial weight loss programs (e.g., Weight Watchers, Jenny Craig, HMR, Omada...
  • Severe illness from any cause
  • Diagnosis of bulimia or history of purging behavior
  • Active enrollment in pulmonary rehabilitation
  • Safety and/or adherence concerns due to severe physical or mental health issues or life expectancy \< 12 months. These include but may not be limited...
See the full eligibility criteria
Who can join
  • COPD: Defined by presence of airflow obstruction (FEV1/FVC \< 0.70) on post-bronchodilator spirometry
  • ≥10 pack year history of tobacco use
  • Self-reported clinician diagnosis of OSA (or presence of OSA on research HSAT)
  • BMI ≥ 25 kg/m2
  • Symptoms of dyspnea defined by MMRC score of ≥1
What rules you out
  • Self-report of weight change \>15 lbs. during prior 3 months
  • Current active weight loss treatment, including: 1) research-based commercial weight loss programs (e.g., Weight Watchers, Jenny Craig, HMR, Omada, TOPS, MOVE!); 2) other weight loss or related behavioral health or...
  • Severe illness from any cause
  • Diagnosis of bulimia or history of purging behavior
  • Active enrollment in pulmonary rehabilitation
  • Safety and/or adherence concerns due to severe physical or mental health issues or life expectancy \< 12 months. These include but may not be limited to: unstable cardiac arrhythmias, active or recent (within one month)...
  • Pregnant, lactating, or planning to become pregnant during the study period
  • Participation in other intervention studies.
  • Prisoner
  • Unable to complete surveys in English

The study team makes the final eligibility decision.

Where it's taking place

  • Boise, Idaho, United States
  • Chicago, Illinois, United States
  • Minneapolis, Minnesota, United States
  • Seattle, Washington, United States
  • Spokane, Washington, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Boise, Idaho, United States; Chicago, Illinois, United States; Minneapolis, Minnesota, United States; Seattle, Washington, United States; Spokane, Washington, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.